EllaOne Concerns Pro-Life Advocates, FDA Hearing Soon

The relatively new abortion drug ellaOne still concerns pro-life advocates, who are monitoring the Food and Drug Administration and whether it will allow the drug to come to the United States from Europe. Billed by abortion backers as a morning-after pill, the drug works much differently. While the morning after pill has the ability to cause an abortion when used after implantation, ellaOne, also known as Ulipristal, works as an abortion drug. That's because the drug is meant to be taken by women longer after sexual intercourse -- not just 24-48 hours but as much as five days later. At that point, if a pregnancy has occurred, the drug will undoubtedly cause an abortion and kill a unique human being immediately after conception. LifeNews